AUROVELA 24 FE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aurovela 24 Fe, and what generic alternatives are available?
Aurovela 24 Fe is a drug marketed by Aurobindo Pharma and is included in one NDA.
The generic ingredient in AUROVELA 24 FE is ethinyl estradiol; norethindrone acetate. There is one drug master file entry for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AUROVELA 24 FE?
- What are the global sales for AUROVELA 24 FE?
- What is Average Wholesale Price for AUROVELA 24 FE?
Summary for AUROVELA 24 FE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| DailyMed Link: | AUROVELA 24 FE at DailyMed |
US Patents and Regulatory Information for AUROVELA 24 FE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | AUROVELA 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 207504-001 | Jun 15, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
